Apollo Hospitals Enterprise Ltd

NSE: APOLLOHOSP BSE: 508869

₹7769

-102 (1.30%)

Thu, 22 Oct 2026, 06:20 pm

MTF 5xInvest in Apollo Hospitals Enterprise Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)113201.66

PE Ratio53.49

Dividend0.26

Health Services

Hospital/Nursing Management

24.5K

Apollo Hospitals Enterprise Ratios

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Price to earnings ratio	47.85	26.97	37.44	24.61	32.88	32.79	39.19	38.10	40.22	55.89	77.95	73.47	125.91	71.98	34.81	270.20	61.52	75.65	101.64	65.85
Price to book ratio	4.15	3.40	2.29	1.67	2.74	3.10	3.43	4.22	4.28	5.99	5.53	4.90	4.55	5.10	4.74	9.07	11.55	10	13.17	11.59
Price to sales ratio	3.27	2.71	2.38	1.56	2.23	2.32	2.74	3.08	2.91	3.70	3	2.24	1.79	1.77	1.41	3.85	4.43	3.73	4.79	4.37
Price to cash flow ratio	27.11	25.62	43.26	32.64	27.66	31.57	26.50	31.53	48.49	52.24	42.08	53.92	61.58	30.44	21.29	49.10	43.97	52.75	55.13	49.37
Enterprise value	2762Cr	2893Cr	3327Cr	3128Cr	5149Cr	6837Cr	9085Cr	12129Cr	13676Cr	20539Cr	20877Cr	18854Cr	17868Cr	20379Cr	21040Cr	43276Cr	67859Cr	65561Cr	95430Cr	101000Cr
Enterprise value to EBITDA ratio	22.65	18.83	18.07	15.16	16.92	16.14	17.58	19.81	20.24	27.81	29.68	25.38	22.06	18.86	13.14	37.15	30.75	31.53	39.59	32.94
Debt to equity ratio	0.46	0.47	0.41	0.45	0.55	0.50	0.33	0.44	0.45	0.63	0.85	0.94	1.05	1.10	1.68	0.90	0.72	0.70	0.77	0.96
Return on equity %	9.92	13.90	7.52	7.41	8.81	10.36	9.96	11.59	11.07	11.06	7.27	6.65	3.58	7.17	13.63	3.79	20.65	13.86	13.68	19.09

Apollo Hospitals Enterprise Ltd Ratios

The Apollo Hospitals Enterprise Ltd Ratios page provides a complete fundamental analysis of Apollo Hospitals Enterprise Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Apollo Hospitals Enterprise Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP, BSE: 508869) is currently trading at ₹7769, with a market capitalization of ₹113201.66Cr. As a major player in the Health services sector and Hospital/Nursing management industry, Apollo Hospitals Enterprise Ltd remains a key stock for fundamental analysis using Apollo Hospitals Enterprise Ltd Ratios.

Apollo Hospitals Enterprise Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Apollo Hospitals Enterprise Ltd P/E ratio currently stands at 65.85, making it one of the most tracked metrics in Apollo Hospitals Enterprise Ltd Ratios.

Historically, the Apollo Hospitals Enterprise Ltd P/E ratio has shown strong fluctuations:

2025: 65.85
2024: 101.64
2023: 75.65
2022: 61.52
2021: 270.20

The decline in Apollo Hospitals Enterprise Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Apollo Hospitals Enterprise Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 11.59.

Historical P/B trend:

2025: 11.59
2024: 13.17
2023: 10
2022: 11.55

Apollo Hospitals Enterprise Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Apollo Hospitals Enterprise Ltd P/S ratio currently stands at 4.37, an important part of Apollo Hospitals Enterprise Ltd Ratios for revenue valuation.

Historical P/S ratio:

2025: 4.37
2024: 4.79
2023: 3.73
2022: 4.43

A stable or declining Apollo Hospitals Enterprise Ltd P/S ratio indicates cautious market sentiment.

Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio (P/CF)

The Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 49.37.

Historical Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio:

2025: 49.37
2024: 55.13
2023: 52.75
2022: 43.97
2021: 49.10

The declining Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Apollo Hospitals Enterprise Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Apollo Hospitals Enterprise Ltd EV currently stands at ₹101000Cr, representing the total company valuation including debt.

Historical EV trend:

2025: 101000Cr
2024: 95430Cr
2023: 65561Cr
2022: 67859Cr

Apollo Hospitals Enterprise Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Apollo Hospitals Enterprise Ltd EV/EBITDA ratio is currently 32.94, a key metric in Apollo Hospitals Enterprise Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

2025: 32.94
2024: 39.59
2023: 31.53
2022: 30.75

Stable Apollo Hospitals Enterprise Ltd EV/EBITDA indicates balanced valuation.

Apollo Hospitals Enterprise Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Apollo Hospitals Enterprise Ltd D/E ratio is currently 0.96, reflecting leverage and financial stability.

Historical D/E:

2025: 0.96
2024: 0.77
2023: 0.70
2022: 0.72

Apollo Hospitals Enterprise Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Apollo Hospitals Enterprise Ltd ROE currently stands at 19.09%, showing profitability and capital efficiency.

Historical ROE:

2025: 19.09
2024: 13.68
2023: 13.86
2022: 20.65

Apollo Hospitals Enterprise Ltd maintains stable profitability levels.

Apollo Hospitals Enterprise Ltd Ratios Analysis Summary

The Apollo Hospitals Enterprise Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Apollo Hospitals Enterprise Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Apollo Hospitals Enterprise Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.